GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 348 filers reported holding GLOBUS MED INC in Q4 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $834 | +73.0% | 16,798 | +107.5% | 0.01% | +150.0% |
Q2 2023 | $482 | -74.1% | 8,096 | -75.3% | 0.00% | -81.8% |
Q1 2023 | $1,860 | +52.5% | 32,833 | +99.8% | 0.02% | +46.7% |
Q4 2022 | $1,220 | -99.9% | 16,429 | -42.4% | 0.02% | -28.6% |
Q3 2022 | $1,698,000 | +9.0% | 28,509 | +2.7% | 0.02% | +23.5% |
Q2 2022 | $1,558,000 | -15.9% | 27,756 | +10.6% | 0.02% | +21.4% |
Q1 2022 | $1,852,000 | +69.0% | 25,102 | +65.4% | 0.01% | +133.3% |
Q4 2021 | $1,096,000 | +40.0% | 15,176 | +48.5% | 0.01% | +50.0% |
Q3 2021 | $783,000 | -83.9% | 10,218 | -83.8% | 0.00% | -82.6% |
Q2 2021 | $4,877,000 | +287.1% | 62,911 | +207.8% | 0.02% | +228.6% |
Q1 2021 | $1,260,000 | -68.7% | 20,439 | -66.9% | 0.01% | -68.2% |
Q4 2020 | $4,028,000 | +398.5% | 61,766 | +278.4% | 0.02% | +340.0% |
Q3 2020 | $808,000 | +81.2% | 16,322 | +74.7% | 0.01% | +25.0% |
Q2 2020 | $446,000 | -58.2% | 9,343 | -62.8% | 0.00% | -60.0% |
Q1 2020 | $1,068,000 | -16.3% | 25,115 | +15.9% | 0.01% | -16.7% |
Q4 2019 | $1,276,000 | +329.6% | 21,667 | +272.7% | 0.01% | +500.0% |
Q3 2019 | $297,000 | -71.9% | 5,813 | -76.7% | 0.00% | -71.4% |
Q2 2019 | $1,057,000 | +255.9% | 24,991 | +315.3% | 0.01% | +133.3% |
Q1 2019 | $297,000 | +13.4% | 6,017 | -0.6% | 0.00% | +50.0% |
Q4 2018 | $262,000 | -74.8% | 6,053 | -67.0% | 0.00% | -75.0% |
Q3 2018 | $1,041,000 | -52.9% | 18,344 | -58.1% | 0.01% | -60.0% |
Q2 2018 | $2,208,000 | -6.0% | 43,758 | -7.2% | 0.02% | +5.3% |
Q1 2018 | $2,349,000 | +11.3% | 47,145 | -8.2% | 0.02% | -5.0% |
Q4 2017 | $2,110,000 | +140.0% | 51,346 | +73.7% | 0.02% | +150.0% |
Q3 2017 | $879,000 | -44.6% | 29,565 | -38.2% | 0.01% | -42.9% |
Q2 2017 | $1,587,000 | +34.2% | 47,862 | +19.9% | 0.01% | +40.0% |
Q1 2017 | $1,183,000 | +37.7% | 39,925 | +15.3% | 0.01% | +42.9% |
Q4 2016 | $859,000 | -8.6% | 34,630 | -16.8% | 0.01% | -30.0% |
Q3 2016 | $940,000 | +92.6% | 41,639 | +103.5% | 0.01% | +233.3% |
Q2 2016 | $488,000 | -33.2% | 20,460 | -33.4% | 0.00% | -40.0% |
Q1 2016 | $730,000 | +371.0% | 30,742 | +309.6% | 0.01% | +400.0% |
Q3 2015 | $155,000 | -9.9% | 7,506 | -23.6% | 0.00% | 0.0% |
Q3 2013 | $172,000 | +47.0% | 9,831 | +41.9% | 0.00% | 0.0% |
Q2 2013 | $117,000 | – | 6,926 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |